DETROIT, MI — A new study from the Henry Ford Health System may provide more legitimacy on the use of hydroxychloroquine to treat COVID-19. Henry Ford published the peer-reviewed study on July 1, using a large-scale retrospective analysis of patients from March 10 to May 2. The study looked over 2,500 hospitalized patients from the Henry Ford’s six hospitals, said Dr. Marcus Zervos, division head of infectious disease for Henry Ford Health System.

Read More